Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,67 USD | +1,21 % | -4,02 % | +4,38 % |
28/03 | Reneo Pharmaceuticals, Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
2023 | RENEO PHARMACEUTICALS, INC. : Ladenburg Thalmann es ahora neutral | ZM |
Resumen de negocios
Número de empleados: 8
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Niall O'Donnell
FOU | Founder | 51 | - |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Jennifer P. Lam
ADM | Chief Administrative Officer | - | 01/08/21 |
Michael Cruse
COO | Chief Operating Officer | 52 | 01/12/20 |
Chief Tech/Sci/R&D Officer | 64 | 01/01/18 | |
Ashley Hall
PRN | Corporate Officer/Principal | 52 | 11/10/21 |
Corporate Officer/Principal | - | 01/01/18 | |
Wendy Johnson
PRN | Corporate Officer/Principal | 72 | 01/01/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Director/Board Member | 64 | 01/12/17 | |
Paul Hoelscher
BRD | Director/Board Member | 59 | 20/01/22 |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Stacey Seltzer
BRD | Director/Board Member | 47 | 01/12/20 |
Niall O'Donnell
FOU | Founder | 51 | - |
Bali Muralidhar
BRD | Director/Board Member | 44 | 01/04/21 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 01/01/22 |
Eric Dube
BRD | Director/Board Member | 51 | 15/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 33 420 808 | 32 416 707 ( 97,00 %) | 0 | 97,00 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,38 % | 55,81 M | |
+1,51 % | 42,75 mil M | |
+8,57 % | 41,34 mil M | |
+49,22 % | 41,61 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción RPHM
- Empresa Reneo Pharmaceuticals, Inc.